Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Symptomatic Adenomyosis
NCT03520439Phase 3Completed
- Start
- May 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone in adenomyosis. Started May 2018; status: completed.
02
Drugs
mifepristone
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT03520439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520439.